Cart
sales@molnova.com
ICA 110381
CAS No. 325457-99-6
ICA 110381( —— )
Catalog No. M20949 CAS No. 325457-99-6
ICA 110381 is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 32 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 80 | In Stock |
|
| 100MG | 110 | In Stock |
|
| 200MG | 161 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameICA 110381
-
NoteResearch use only, not for human use.
-
Brief DescriptionICA 110381 is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy.
-
DescriptionICA 110381 is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorKCNQ2/Q3 potassium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number325457-99-6
-
Formula Weight267.11
-
Molecular FormulaC12H8Cl2N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(Nc1ccc(Cl)nc1)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Amato G Roeloffs R Rigdon G C et al. N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy[J]. ACS Medicinal Chemistry Letters 2011 2(6):481.
molnova catalog
related products
-
XE-991
XE-991 is a potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.
-
Gliclazide
Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM.
-
Senicapoc
A potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM).
